Indegene Limited (NSE:INDGN)
India
· Delayed Price · Currency is INR 533.60
-1.45 (-0.27%)
At close: Dec 5, 2025
Indegene Revenue
Indegene had revenue of 8.04B INR in the quarter ending September 30, 2025, with 17.09% growth. This brings the company's revenue in the last twelve months to 30.41B, up 12.23% year-over-year. In the fiscal year ending March 31, 2025, Indegene had annual revenue of 28.39B with 9.64% growth.
Revenue (ttm)
30.41B
Revenue Growth
+12.23%
P/S Ratio
4.21
Revenue / Employee
7.31M
Employees
4,158
Market Cap
128.07B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Fortis Healthcare | 84.37B |